In a similar approach, Wang et al. constructed the manganese superoxide dismutase-armed oncolytic Ad ZD55-MnSOD and used it together with cisplatin, achieving enhanced cisplatin-induced growth suppression and apoptosis in ovarian cancer cells lines and ovarian tumour xenografts [44]. Here, SOD2 is linked to ovarian cancer.